TNFSF12-TNFSF13
Basic information
Region (hg38): 17:7549099-7561601
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFSF12-TNFSF13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 40 | 44 | ||||
missense | 74 | 75 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 6 | 8 | 1 | 15 | ||
non coding | 35 | 40 | 11 | 86 | ||
Total | 0 | 0 | 118 | 80 | 16 |
Variants in TNFSF12-TNFSF13
This is a list of pathogenic ClinVar variants found in the TNFSF12-TNFSF13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-7549159-C-G | Likely benign (Jun 01, 2018) | |||
17-7549164-G-C | Common variable immunodeficiency | Uncertain significance (Oct 14, 2022) | ||
17-7549176-G-A | Common variable immunodeficiency | Uncertain significance (Aug 28, 2021) | ||
17-7549179-G-A | Common variable immunodeficiency | Uncertain significance (Jul 22, 2021) | ||
17-7549182-G-C | Common variable immunodeficiency | Uncertain significance (Jun 14, 2023) | ||
17-7549188-G-C | Common variable immunodeficiency | Uncertain significance (Nov 28, 2023) | ||
17-7549191-G-A | Common variable immunodeficiency | Uncertain significance (Aug 24, 2021) | ||
17-7549195-G-A | Common variable immunodeficiency | Likely benign (Aug 30, 2023) | ||
17-7549196-G-A | Common variable immunodeficiency • See cases | Uncertain significance (Jan 29, 2024) | ||
17-7549199-C-A | Common variable immunodeficiency | Uncertain significance (Nov 27, 2023) | ||
17-7549204-C-A | Common variable immunodeficiency | Likely benign (Nov 15, 2022) | ||
17-7549207-C-T | Common variable immunodeficiency | Likely benign (Nov 06, 2023) | ||
17-7549208-G-A | Common variable immunodeficiency | Uncertain significance (Jan 06, 2024) | ||
17-7549212-T-C | Common variable immunodeficiency | Uncertain significance (Sep 15, 2022) | ||
17-7549213-G-C | Common variable immunodeficiency | Likely benign (Feb 20, 2022) | ||
17-7549213-G-T | Common variable immunodeficiency | Likely benign (Oct 15, 2020) | ||
17-7549217-G-C | Common variable immunodeficiency | Uncertain significance (Sep 11, 2018) | ||
17-7549221-C-T | Common variable immunodeficiency | Uncertain significance (Aug 15, 2022) | ||
17-7549222-G-A | Common variable immunodeficiency | Likely benign (May 24, 2023) | ||
17-7549225-C-T | Common variable immunodeficiency | Benign (Jan 31, 2024) | ||
17-7549228-GCTGGGC-G | Common variable immunodeficiency | Uncertain significance (Feb 11, 2023) | ||
17-7549228-G-GCTGGGC | Common variable immunodeficiency | Uncertain significance (Dec 07, 2022) | ||
17-7549233-G-T | Common variable immunodeficiency | Uncertain significance (Dec 31, 2022) | ||
17-7549240-C-T | Common variable immunodeficiency | Likely benign (Apr 10, 2022) | ||
17-7549241-C-G | Common variable immunodeficiency | Uncertain significance (Mar 28, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNFSF12-TNFSF13 | protein_coding | protein_coding | ENST00000293826 | 11 | 12503 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.770 | 0.230 | 124514 | 0 | 15 | 124529 | 0.0000602 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.983 | 137 | 173 | 0.790 | 0.0000101 | 2068 |
Missense in Polyphen | 31 | 55.131 | 0.56229 | 612 | ||
Synonymous | -0.330 | 74 | 70.5 | 1.05 | 0.00000413 | 699 |
Loss of Function | 3.60 | 4 | 22.4 | 0.178 | 0.00000137 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000461 | 0.000460 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000607 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000269 | 0.0000269 |
Middle Eastern | 0.0000607 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to FN14 and possibly also to TNRFSF12/APO3. Weak inducer of apoptosis in some cell types. Mediates NF-kappa-B activation. Promotes angiogenesis and the proliferation of endothelial cells. Also involved in induction of inflammatory cytokines. Promotes IL8 secretion. {ECO:0000269|PubMed:10085077, ECO:0000269|PubMed:23667509}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.29
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.519
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnfsfm13
- Phenotype
Gene ontology
- Biological process
- immune response;regulation of signaling receptor activity
- Cellular component
- extracellular space;membrane
- Molecular function
- cytokine activity;tumor necrosis factor receptor binding